Skip to main content

Tags: Nanoparticle

All Categories (1-20 of 24)

  1. Accelerating Nanotech Innovations Through a Safer-By-Design Approach, Safer Nanomaterials School

    14 May 2019 | Contributor(s):: Philippe Sabatier

    Nano WG May 9, 2019European Scientific Institute (ESI) Safer Nanomaterials School Introduction.

  2. caNanoLab: data sharing to expedite the use of nanotechnology in biomedicine

    13 Dec 2013 | | Contributor(s):: Sharon Gaheen, George W Hinkal, Stephanie A Morris, Michal Lijowski, Mervi Heiskanen, Juli Klemm

    The use of nanotechnology in biomedicine involves the engineering of nanomaterials to act as therapeutic carriers, targeting agents and diagnostic imaging devices. The application of nanotechnology in cancer aims to transform early detection, targeted therapeutics and cancer prevention and...

  3. Development of natural language processing tools for nanoparticle design

    05 Mar 2019 | | Contributor(s):: Nastassja Lewinski

    Nano WG February 28, 2019: In this presentation, an introduction to the application of natural language processing techniques to nanotechnology data will be discussed.  Natural language processing tools can aid in the automatic categorization, extraction, and analysis of data from...

  4. Development of Targeted Nanomedicines via Machine Learning Processes

    05 Mar 2019 | | Contributor(s):: Daniel Heller

    Nano WG February 21, 2019Description: We are using data science to facilitate the development of nanoparticle drugs incorporating kinase inhibitors with diverse chemical structures. Doing this work inspired us to bring together the nanoinformatics community...

  5. NCI Alliance for Nanotechnology in Cancer, and caNanoLab: A Data Repository for Cancer Nanomedicines

    27 Nov 2018 | | Contributor(s):: Luisa Russell, Mervi Heiskanen

    Nano WG presentation November15, 2018 NCI Alliance for Nanotechnology in Cancer –Structure–Achievements–Scientific FocuscaNanoLab–Intro to Platform–Data Curation–User Statistics–Future Directions

  6. NCL Method GTA-13

    17 Mar 2020 | Datasets | Contributor(s):

    By Stephan Stern

    In Vitro Blood Partitioning Assay

    https://ncihub.cancer.gov/publications/131/?v=1

  7. NCL Method IEA-1

    09 Jun 2020 | Datasets | Contributor(s):

    By Julia Bui1, Edward Cedrone1, Naichen Yu1, Marina Dobrovolskaia

    Leidos Biomedical Research, Inc.

    Analysis of nanoparticle effects on invasion of cancer cells

    https://ncihub.cancer.gov/publications/203/?v=1

  8. NCL Method ITA-12

    23 Mar 2020 | Datasets | Contributor(s):

    By Barry Neun, Jamie Rodriguez, Anna Ilinskaya, Marina Dobrovolskaia

    Analysis of Nanoparticle Effects onPlasma Coagulation Times in Vitro

    https://ncihub.cancer.gov/publications/147/?v=1

  9. NCL Method ITA-12

    25 Jun 2020 | Datasets | Contributor(s):

    By Edward Cedrone, Timothy Potter, Barry Neun, Marina Dobrovolskaia

    In vitro Analysis of Nanoparticle Effects on Plasma Coagulation Time

    https://ncihub.cancer.gov/publications/147/?v=2

  10. NCL Method ITA-2.1

    12 Jun 2020 | Datasets | Contributor(s):

    By Barry Neun, Edward Cedrone, Marina Dobrovolskaia

    Analysis of Platelet Aggregation By Cell Counting

    https://ncihub.cancer.gov/publications/134/?v=2

  11. NCL Method ITA-2.2

    15 Jun 2020 | Datasets | Contributor(s):

    By Jamie Rodriguez, Edward Cedrone, Barry Neun, Marina Dobrovolskaia

    Analysis of Platelet Aggregation by Light Transmission Aggregometry

    https://ncihub.cancer.gov/publications/135/?v=2

  12. NCL Method ITA-5.1

    15 Jun 2020 | Datasets | Contributor(s):

    By Barry Neun, Edward Cedrone, Marina Dobrovolskaia

    Qualitative Analysis of Total Complement Activation by Western Blot

    https://ncihub.cancer.gov/publications/138/?v=2

  13. NCL Method ITA-8

    19 Mar 2020 | Datasets | Contributor(s):

    By Sarah Skoczen, Barry Neun, Timothy Potter, Jamie Rodriguez, Anna Ilinskaya, Marina Dobrovolskaia

    Chemotaxis Assay

    https://ncihub.cancer.gov/publications/142/?v=1

  14. NCL Method ITA-8.1

    19 Jun 2020 | Datasets | Contributor(s):

    By Timothy Potter, Edward Cedrone, Barry Neun, Marina Dobrovolskaia

    Chemotaxis Assay

    https://ncihub.cancer.gov/publications/208/?v=1

  15. NCL Method ITA-8.2

    22 Jun 2020 | Datasets | Contributor(s):

    By Edward Cedrone, Julia Bui, Naichen Yu, Marina Dobrovolskaia

    Analysis of nanoparticle chemoattractant properties using label-free, real-time chemotaxis assay

    https://ncihub.cancer.gov/publications/209/?v=1

  16. NCL Method PCC-16

    02 Apr 2020 | Datasets | Contributor(s):

    By Jeffrey Clogston, Mackensie Smith1

    Leidos Biomedical Research, Inc.

    Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection

    https://ncihub.cancer.gov/publications/183/?v=1

  17. NCL Method PCC-16

    09 Jul 2020 | Datasets | Contributor(s):

    By Jeffrey Clogston, Mackensie Smith1

    Leidos Biomedical Research, Inc.

    Quantitation of PEG on PEGylated Gold Nanoparticles Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection

    https://ncihub.cancer.gov/publications/183/?v=2

  18. NCL Method PCC-17

    07 May 2020 | Datasets | Contributor(s):

    By Alpana Dongargonkar, Jeffrey Clogston, Alison Vermilya1

    Leidos Biomedical Research, Inc.

    Quantitation of Nanoparticle Composition Using Thermogravimetric Analysis

    https://ncihub.cancer.gov/publications/190/?v=1

  19. NCL Method PCC-21

    04 Feb 2021 | Datasets | Contributor(s):

    By Matthew Hansen, Jeffrey Clogston

    Measuring Size and Number Concentration of Metallic Nanoparticles using SP-ICP-MS

    https://ncihub.cancer.gov/publications/248/?v=1

  20. NCL Method PHA-1

    02 Apr 2020 | Datasets | Contributor(s):

    By Stephan Stern

    Radioactive Blood Partitioning Assay

    https://ncihub.cancer.gov/publications/186/?v=1